Gennex Laboratories share news and announcements

BSE: 531739Pharmaceuticals & BiotechnologySmall Cap

₹8.70₹0.15 (1.69%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹8.85.

52-week range of traded prices to 23 Oct 2026

₹7.05Low, 30 Mar 2026₹17.25High, 28 Oct 2025

Market cap: ₹211 Cr2,248th largest listed
P/E: 11.5
P/B: 0.9
Dividend yield: Nonein the last 12 months
ROE: 9.0%
ROCE: 7.0%
Debt to equity: 0.15
Volume, BSE: 2,30,459

Gennex Laboratories board meetings

159 filed, newest first. Page 1 of 4.

Sep 2026
- 4 Sep · Board meeting
  1. Draft Directors'/ Board Report for the Financial Year March 31, 2026; 2. The 41st Annual General Meeting of the Company to be held on Wednesday, September 30, 2026 at 12:30 P.M. through .... (opens in a new tab)
Aug 2026
- 27 Aug · Board meeting
  Meeting on 4 Sep 2026: annual general meeting
- 27 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve 1. To decide regarding .... (opens in a new tab)
Jul 2026
- 29 Jul · Board meeting
  Meeting on 14 Aug 2026: quarterly results
- 29 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Unaudited Financial .... (opens in a new tab)
May 2026
- 19 May · Board meeting
  Meeting on 30 May 2026: audited results
- 19 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve With reference to the above .... (opens in a new tab)
Apr 2026
- 17 Apr · Board meeting
  Revised outcome With reference to our earlier letter dated April 16, 2026, in this connection we would like to submit the revised outcome of the Board Meeting as follows: 1. Convening .... (opens in a new tab)
- 16 Apr · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Convening of an Extraordinary General Meeting ('EGM') of the Company on Tuesday, .... (opens in a new tab)
- 8 Apr · Board meeting
  Meeting on 16 Apr 2026
- 8 Apr · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 16/04/2026 ,inter alia, to consider and approve 1. To decide regarding .... (opens in a new tab)
Feb 2026
- 5 Feb · Board meeting
  Meeting on 14 Feb 2026: quarterly results
- 5 Feb · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve 1. Consider and adopt the .... (opens in a new tab)
Nov 2025
- 4 Nov · Board meeting
  Meeting on 14 Nov 2025: quarterly results
- 4 Nov · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve 1. The Unaudited Financial .... (opens in a new tab)
Sep 2025
- 4 Sep · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Draft Directors'/ Board Report for the Financial Year March 31, 2025; 2. The .... (opens in a new tab)
Aug 2025
- 26 Aug · Board meeting
  Meeting on 4 Sep 2025: annual general meeting
- 26 Aug · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 04/09/2025 ,inter alia, to consider and approve With reference to the above .... (opens in a new tab)
Jul 2025
- 28 Jul · Board meeting
  Meeting on 14 Aug 2025: quarterly results
- 28 Jul · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. the Unaudited Financial .... (opens in a new tab)
- 8 Jul · Board meeting
  Meeting on 8 Jul 2025: preferential issue of shares
- 8 Jul · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 .... (opens in a new tab)
- 4 Jul · Board meeting
  Meeting on 4 Jul 2025: preferential issue of shares
- 4 Jul · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 .... (opens in a new tab)
Jun 2025
- 4 Jun · Board meeting
  Meeting on 4 Jun 2025: preferential issue of shares
- 4 Jun · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 ('Listing Regulations') read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, .... (opens in a new tab)
May 2025
- 30 May · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the Quarter & Year .... (opens in a new tab)
- 20 May · Board meeting
  Meeting on 30 May 2025: audited results
- 20 May · Board meeting
  Meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve 1. Consider and adopt the .... (opens in a new tab)
Feb 2025
- 3 Feb · Board meeting
  Meeting on 14 Feb 2025: quarterly results
- 3 Feb · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve 1. Consider and adopt .... (opens in a new tab)
Nov 2024
- 5 Nov · Board meeting
  Meeting on 14 Nov 2024: quarterly results
- 5 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve 1. Consider and adopt .... (opens in a new tab)
Sep 2024
- 6 Sep · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Draft Directors'/ Board Report for the Financial Year March 31, 2024; 2. The .... (opens in a new tab)
Aug 2024
- 28 Aug · Board meeting
  Meeting on 6 Sep 2024: annual general meeting
- 28 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2024 ,inter alia, to consider and approve 1. To decide regarding .... (opens in a new tab)
- 14 Aug · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 5 Aug · Board meeting
  Meeting on 14 Aug 2024: quarterly results
- 5 Aug · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 ,inter alia, to consider and approve With reference to the .... (opens in a new tab)
May 2024
- 30 May · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Audited Standalone & Consolidated Financial results for the quarter ended & .... (opens in a new tab)
- 21 May · Board meeting
  Meeting on 30 May 2024: audited results
- 21 May · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve 1. Audited Financial Statements .... (opens in a new tab)
Feb 2024
- 14 Feb · Board meeting
  In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter .... (opens in a new tab)
- 1 Feb · Board meeting
  Meeting on 14 Feb 2024: quarterly results
- 1 Feb · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve 1. Consider and adopt .... (opens in a new tab)
Jan 2024
- 27 Jan · Board meeting
  Read with Schedule III thereto, and in furtherance to our intimation dated 20/11/2023, 29/11/2023, and Board meeting outcome .... (opens in a new tab)
Dec 2023
- 2 Dec · Board meeting
  Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015 in furtherance to our intimation dated 20/11/2023 and 29/11/2023, we wish to inform you that Board of Directors .... (opens in a new tab)
Nov 2023
- 29 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2023 ,inter alia, to consider and approve This intimation is revision .... (opens in a new tab)
- 20 Nov · Board meeting
  Meeting on 2 Dec 2023: increase in authorised capital and preferential issue of shares
- 20 Nov · Board meeting
  GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/12/2023 ,inter alia, to consider and approve We hereby inform you that .... (opens in a new tab)

Gennex Laboratories board meetings

Sep 2026

Aug 2026

Jul 2026

May 2026

Apr 2026

Feb 2026

Nov 2025

Sep 2025

Aug 2025

Jul 2025

Jun 2025

May 2025

Feb 2025

Nov 2024

Sep 2024

Aug 2024

May 2024

Feb 2024

Jan 2024

Dec 2023

Nov 2023